ICH Impurity Thresholds are Unrealistic for Antibiotics
This article was originally published in The Gold Sheet
EMA's proposal to apply the same ICH impurity limits to antibiotics produced by fermentation and semi-synthetic methods as new drug substances is considered unrealistic, and could result in market withdrawals of these products.
You may also be interested in...
Proposal could yield a bounty of new options for innovative drug delivery systems.
Data integrity issues were raised in many warning letters to active pharmaceutical ingredient manufacturers over the past four years.
FDA’s draft guidance on transdermal and topical delivery systems says manufacturers can leverage pharmaceutical development studies principles for device design control requirements.